Companies/JP/4564

ONCOTHERAPY SCIENCE, INC. · オンコセラピー.サイエンス株式会社

Income flow

Annual
4564 ANNUAL Income StatementPeriod 2026-03-31Source ANNUAL
Cancer Precision Medical BusinessJPY 806MResearch And Development Of Pharmaceutical ProductsJPY 3MRevenueJPY 809M+8% Y/YGross profitJPY 14MCost of revenueJPY 795M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2026-03-31 · ANNUAL · JPY
By activity
By activityJPY 809M
  • Cancer Precision Medical BusinessJPY 806M99.7%
  • Research And Development Of Pharmaceutical ProductsJPY 3M0.3%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).408.2MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).375.8M
Stock splits
  1. 500:12013-09-26